Genius Sports Ltd
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.
Analysts made multiple rating changes: Wells Fargo initiated Johnson Controls (JCI) as overweight, UBS initiated Chemed (CHE) as buy, Mizuho reiterated SpaceX as outperform, Barclays initiated Ligand Pharmaceuticals (LGND) as overweight, Seaport reiterated Nvidia (NVDA) as sell, UBS upgraded Stem (STEM) to buy, HSBC upgraded BP (BP) to buy, Bernstein initiated CF Industries (CF) as outperform, Bank of America reiterated AMD (AMD) as buy, Bernstein reiterated Apple (AAPL) as outperform, JPMorgan…
Russell Thomas (Chief Legal Officer) sold 50,000 shares of Genius Sports Ltd (GENI) at $6.51 ($0.33M total) on 2026-09-17.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning GENI (Genius Sports Ltd). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent GENI coverage spans financial news, earnings and insider activity.
In the last 30 days, GENI insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($5.6M). The most active reporter was Locke Mark, Chief Executive Officer, with 3 filings.
Potential price appreciation if growth assumptions materialize.
Overweight initiation could drive buying.
Insider sale may signal lack of confidence, could pressure stock short-term.
Insider sale may signal reduced confidence, potentially pressuring the stock short-term.
Raised guidance after a revenue beat, while losses widened, suggesting investors are underwriting growth spend and betting-market momentum.
AlphAI scores every news story that mentions GENI with an AI model for sentiment and relevance, and aggregates insider trades from Genius Sports Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.
2 min readAnalysts made multiple rating changes: Wells Fargo initiated Johnson Controls (JCI) as overweight, UBS initiated Chemed (CHE) as buy, Mizuho reiterated SpaceX as outperform, Barclays initiated Ligand Pharmaceuticals (LGND) as overweight, Seaport reiterated Nvidia (NVDA) as sell, UBS upgraded Stem (STEM) to buy, HSBC upgraded BP (BP) to buy, Bernstein initiated CF Industries (CF) as outperform, Bank of America reiterated AMD (AMD) as buy, Bernstein reiterated Apple (AAPL) as outperform, JPMorgan…
3 min readRussell Thomas (Chief Legal Officer) sold 50,000 shares of Genius Sports Ltd (GENI) at $6.51 ($0.33M total) on 2026-09-17.
1 min readLocke Mark (Chief Executive Officer) sold 800,000 shares of Genius Sports Ltd (GENI) at an average of $6.57 ($6.54–$6.58, $5.26M total) across 3 trades over 2026-09-15 to 2026-09-17.
1 min readGenius Sports (NYSE: GEN) rose nearly 10% over the week after its Q2 results beat revenue expectations and the company raised 2026 guidance. Revenue was $196M versus $185M guidance and just under consensus. Net loss widened to about $77M ($0.28/share). Full-year revenue guidance increased to about $1.03B and adjusted EBITDA to $285M-$295M.
6 min readGenius Sports raised its FY2026 outlook after a Q2 beat. It now expects Group revenue of $1.005B to $1.025B (from $990M to $1.010B) and Adjusted EBITDA of $285M to $295M (from $270M to $280M), implying a ~28.6% margin. Q2 revenue was $195.5M and Adjusted EBITDA $52.6M. Q2 net loss was $76.7M.
4 min readGenius Sports said it signed official sports data agreements with Kalshi and Polymarket to support prediction market contract settlement, plus information sharing and integrity services with market-type restrictions. CEO Mark Locke discussed the deals on a Q2 earnings call. Genius reported Q2 group revenue of $195.5M (+65% YoY) and raised full-year guidance to $1.02B revenue and $290M adjusted EBITDA.
6 min readGenius Sports (GENI) shares fell about 3% to $7.60 after Q2 results. The company reported Q2 revenue of $195.5m (up 65% y/y) and guided full-year revenue to about $1.0b, with adjusted EBITDA of up to $295m. Despite adjusted metrics, statutory net loss widened to $76.7m and basic EPS loss increased to $0.28.
6 min readGenius Sports said it has partnered with Polymarket and Kalshi to provide real-time official sports event data for US-regulated prediction markets. The Polymarket deal covers live event data integrity, while the Kalshi agreement uses Genius Sports’ soccer portfolio including the Premier League and Serie A. Both partnerships take effect immediately for eligible US users.
3 min readGenius Sports CEO Mark Locke said prediction markets are validating its May 1 acquisition of Legend, citing faster-than-expected synergies in customer acquisition, official data and partnerships. He referenced deals with Kalshi and Polymarket and said prediction-market revenue should structurally rise. Genius raised 2026 guidance to revenue $1.01bn-$1.03bn and adjusted EBITDA $285m-$295m.
4 min read
